Gastrointestinal cancer organoids-applications in basic and translational cancer research

Therese Seidlitz1, Daniel E Stange2,3

  • 1Department of Visceral, Thoracic and Vascular Surgery, Medical Faculty and University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.

Insights

Organoid technology offers a promising approach for personalized cancer treatment by creating patient-derived organoid (PDO) models. These models aid in understanding cancer biology and testing drug responses for improved patient outcomes.

Area of Science:

  • Biotechnology
  • Cancer Research
  • Gastroenterology

Background:

  • Cancer remains a leading global cause of death, necessitating advancements in personalized treatment strategies.
  • Targeted therapies offer potential for individualized cancer care, but require predictive biomarkers for drug response.
  • Organoid technology has emerged as a powerful tool for modeling human tissues and diseases.

Purpose of the Study:

  • To review the diverse applications of gastrointestinal organoids in fundamental cancer research.
  • To explore the clinical translational potential of organoid technology in oncology.
  • To highlight patient-derived organoids (PDOs) as valuable tools for personalized medicine.

Main Methods:

  • Generation of patient-derived organoids (PDOs) from various gastrointestinal tissues and cancers.
  • Utilizing PDOs for in-depth analysis of tissue function, development, and cancer pathobiology.
  • Employing PDOs in techniques such as drug screening, targeted therapy testing, and genetic engineering.

Main Results:

  • Organoid cultures recapitulate key aspects of primary tissues, including self-renewal and self-organization.
  • PDO libraries serve as "living" biobanks for comprehensive biological and pathological studies.
  • PDOs demonstrate amenability to diverse analyses, including molecular and therapeutic assessments.

Conclusions:

  • Organoid technology, particularly PDOs, holds significant promise for advancing personalized cancer treatment.
  • Gastrointestinal organoids facilitate the study of cancer biology and offer a platform for clinical translation.
  • PDOs are instrumental in biomarker discovery and optimizing targeted therapy selection in oncology.

Related Concept Videos